LYNN WHEELER: Open Payments
NPI 1295039873 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,645 in 130 payments from 16 companies in 2025. Trend: 2023 $2,109 · 2024 $2,389 · 2025 $2,645
Food & beverage: $2,645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $344 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $329 |
| Neurocrine BioSciences, Inc. | 15 | $315 |
| Otsuka America Pharmaceutical, Inc. | 9 | $205 |
| Teva Pharmaceuticals USA, Inc. | 8 | $168 |
| Axsome Therapeutics, Inc. | 9 | $163 |
| E.R. Squibb & Sons, L.L.C. | 11 | $150 |
| Alkermes, Inc. | 8 | $145 |
| Collegium Pharmaceutical, Inc. | 8 | $144 |
| Supernus Pharmaceuticals, Inc. | 5 | $142 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, REXULTI, Auvelity, AUSTEDO XR, COBENFY, Jornay PM.
Industry payments across IL — which companies pay providers there.
